FAPR | XBAP | FAPR / XBAP | |
Gain YTD | 3.711 | 9.486 | 39% |
Net Assets | 858M | 253M | 339% |
Total Expense Ratio | 0.85 | 0.79 | 108% |
Turnover | 0.00 | N/A | - |
Yield | 0.00 | 0.00 | - |
Fund Existence | 4 years | 4 years | - |
FAPR | XBAP | |
---|---|---|
RSI ODDS (%) | 1 day ago44% | 2 days ago53% |
Stochastic ODDS (%) | 1 day ago55% | 2 days ago47% |
Momentum ODDS (%) | 1 day ago78% | N/A |
MACD ODDS (%) | 1 day ago45% | 2 days ago54% |
TrendWeek ODDS (%) | 1 day ago63% | 2 days ago59% |
TrendMonth ODDS (%) | 1 day ago74% | 2 days ago61% |
Advances ODDS (%) | 9 days ago74% | 4 days ago64% |
Declines ODDS (%) | 7 days ago60% | 2 days ago58% |
BollingerBands ODDS (%) | 1 day ago36% | 2 days ago50% |
Aroon ODDS (%) | 1 day ago72% | 2 days ago56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PZISX | 13.81 | 0.11 | +0.80% |
Pzena Small Cap Value Institutional | |||
RSDFX | 40.53 | 0.13 | +0.32% |
Columbia Dividend Opportunity Inst2 | |||
RETSX | 91.58 | -0.45 | -0.49% |
Russell Inv Tax-Managed US Large Cap S | |||
FBDIX | 129.95 | -1.16 | -0.88% |
Franklin Biotechnology Discovery A | |||
MIEFX | 15.27 | -0.15 | -0.97% |
Matthews Emerging Markets Equity Ins |